Skip to content
DataLookout
Menu

NCT05209841

Heparinization vs Salinization of the Peripheral Venous Catheter

StatusTerminated
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗

  1. Stopped Trial terminated Sponsor's reason: Poor recruitment Show 4 more changesShow less
    • Final enrollment: 289 participants, 8% of the 3450 planned
    • Eligibility criteria expanded, about 14 words
    • Primary completion date changed from estimate of Jul 30, 2026 to Jul 10, 2025
    • Site details revised
  2. Notable Primary and study completion dates: Jul 30, 2025 to Jul 30, 2026v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Jul 30, 2022 to Jul 30, 2025
    • Start date changed from estimate of Mar 16, 2022 to Apr 5, 2022
    • Site details revised
    v3
  4. Notable Start date: Jan 30, 2022 to Mar 16, 2022v2
  5. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed

Endpoints

Primary

Percentage of obstructed catheters
Timeframe: From date of randomization through the date of hospital discharge, an average of 10 days.

Secondary (3)

Number of catheter-associated phlebitis
Number of catheter-associated bacterihemia episodes
Number of catheter loss due to extravasation

Arms and interventions

Catheter sealing with low dose heparinExperimental

Catheters will be sealed with 3mL of Fibrillin Ⓡ (heparin 20UI/mL)

Catheter sealing with normal salineActive comparator

Catheters will be sealed with 3mL of 0.9% sodium chloride

Drugs: Low dose heparin, Normal saline

Sites

1 site in 1 country

  • Hospital Residència Sant CamilSant Pere de Ribes, Barcelona, Spain